medigraphic.com
ISSN 2520-9078 (Electronic)

2016, Number 2

<< Back Next >>

Revista de Ciencias Médicas de la Habana 2016; 22 (2)

Behavior of plasma donations in Primary Health Care

González RR, Cardentey GJ, Corbillón CJC, López-Portilla RM

Language: Spanish
References: 20
Page: 63-72
PDF size: 210.48 Kb.


ABSTRACT

Introduction: plasma donations in Primary Health Care constitutes an altruist act for acquiring plasma with transfusion or prime material goals in therapeutic derivate.
Objective: to characterize the behavior of plasma donations in Primary Health Care.
Methods: a descriptive, observational transversal study was carried out in the provincial Bank of Blood en Pinar del Río, from January to October 2015. The universe was formed by 3 832 plasma donations. The variables: age group, biological sex, health areas, quantity of donations, recollected and used plasma were analyzed.
Results: the male sex, and the 40 a 49 age group prevailed in plasma donations. As well as “Hermanos Cruz” Teaching Polyclinic with 32,3 % of bags of plasma. The highest quantity of donations and recollected plasma was in February with 421 donations and 252 600 mL of plasma. There was a highest use of units of plasma by the Pharmaceutical Industry with a 68,2 %.
Conclusions: plasma donations were characterized prevailing in males between 40 and 49 years old from “Hermanos Cruz” Teaching Polyclinic. February resulted the period of more plasma donations and recollection mainly used by the pharmacological industry. An adequate performance and use of plasma donations was evidenced by the health services which continues requiring the integral assistance and attention.


REFERENCES

  1. OMS [Internet]. Ginebra: OMS; 2014 [citado 12 Abr 2016]. Disponible en: http://www.who.int/bloodsafety/publications/bts_guideline_donor_suitabil ity/en/

  2. Shander A, Gross I, Hill S, Javidroozi M, Sledge S. A new perspective on best transfusion practices. Blood Transfus [Internet]. 2013 [citado 12 Abr 2016];11. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626470/

  3. Bagang E, Szallasi A. Transfusion indication RBC (PBM-02): gap analysis of a Joint Commission Patient Blood Management Performance Measure at a community hospital. Blood Transfus. 2014;12(Suppl 1).

  4. WHO [Internet]. Ginebra: OMS; 2013 [citado 12 Abr 2016]. Disponible en: http://www.who.int/bloodsafety/donation_testing/vnrd/en/

  5. De Vries RP, Faber JC, Strengers PF. Hemovigilance an effective tool for improving transfusion practice. Vox Sang. 2011;100(1):60-7.

  6. Sánchez Frenes P, Fariñas Reinoso AT, Hernández Malpica S. A propósito de la primera edición de un boletín informativo del Sistema de Vigilancia del Banco de Sangre de Cienfuegos. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2011 Jun [citado 12 Abr 2016];27(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892011000200010&lng=es&nrm=iso

  7. Moreira Vicente VF, Garrido Porras E. Anemia megaloblástica y gastritis atrófica. Rev Esp Enferm Dig [Internet]. 2011 Jun [citado 25 Abr 2016];103(6). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130- 01082011000600010&lng=es&nrm=iso

  8. Quevedo Freites G, Vázquez Ortiz ME, Zulueta Yate M, Fernández Charón E, Ruz Domínguez JE. Comportamiento del riesgo preconcepcional en el consultorio médico El Turagual de Venezuela. Rev Cubana Med Gen Integr [Internet]. 2012 Jun [citado 25 Abr 2016];28(2). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21252012000200012&lng=es&nrm=iso

  9. Padro Suárez L, Pelegrín Martínez AA. Perimenopausia y riesgo cardiovascular. MEDISAN [Internet]. 2011 Oct [citado 25 Abr 2016];15(10). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029- 30192011001000018&lng=es&nrm=iso

  10. McLeod BC. Therapeutic apheresis: history, clinical application, and lingering uncertainties. Transfusion. 2010;50(7):1413-26.

  11. Szczepiorkowski ZM, Winter JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher. 2010;25:83-177.

  12. Hernández Ramírez P. Reflexiones sobre la introducción y desarrollo de la terapia celular en Cuba. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2013 Jul [citado 25 Abr 2016];29(3). Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/83/68

  13. Hernández Ramírez P, Forrellat Barrios M. Ventajas de la terapia celular con células mononucleares derivadas de la médula ósea, aplicadas en su conjunto. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2013 Oct-Dic [25 Abr 2016];29(4). Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/127/93

  14. González Suárez T, Fernández Delgado N, Salgado Arocena O, González Iglesias AI, Román Torres R, de la Cruz Zayas N. Procederes de aféresis en el Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2015 Oct [citado 25 Abr 2016];31(4). Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/287/204

  15. Barr PJ, Donnelly M, Morris K. The epidemiology of red cell transfusion. Vox Sang. 2010;99:239-50.

  16. Bagang E, Szallasi A. Transfusion indication RBC (PBM-02): gap analysis of a Joint Commission Patient Blood Management Performance Measure at a community hospital. Blood Transfus 2014;12(Suppl1):187- 90.

  17. Shaz BH, Schwart J and Winters JL. How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedure. Transfussion. 2014;54:17-25.

  18. Fernández Delgado ND, Forrellat Barrios M, González Suárez T, Salgado Arocena O. Plasmaféresis terapéutica. Análisis de 2 años en el Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2012 Jun [citado 25 Abr 2016];28(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892012000200006&lng=es&nrm=iso&tlng=es

  19. Cortina Rosales L, Hernández Ramírez P, López De Roux MR, Artaza Sanz HM, Dorticós Balea E, Macías Abraham C, et al. Aislamiento de células mononucleares de sangre periférica para trasplante de células madre: método simplificado. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2008 [citado 25 Abr 2016];24(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892008000300004&lng=es.

  20. González Suárez T, Fernández Delgado N, Salgado Arocena O, González Iglesias AI, Román Torres R, Cruz Zayas N de la. Procederes de aféresis en el Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2015 [citado 25 Abr 2016];31(4). Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/287/204




2020     |     www.medigraphic.com